Compare MIST & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | SRBK |
|---|---|---|
| Founded | 2003 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 123.7M |
| IPO Year | N/A | N/A |
| Metric | MIST | SRBK |
|---|---|---|
| Price | $2.04 | $15.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 37.8K |
| Earning Date | 11-12-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | N/A | ★ 374.69 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $31,130,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.31 |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $0.63 | $11.36 |
| 52 Week High | $3.06 | $17.11 |
| Indicator | MIST | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 48.79 |
| Support Level | $1.94 | $16.12 |
| Resistance Level | $2.14 | $16.34 |
| Average True Range (ATR) | 0.29 | 0.39 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 29.66 | 22.15 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.